NetworkNewsBreaks Archive - Page 2058 of 2140

TuesdayApr 25, 2017 1:01 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 25, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NMRD 17.14% – News: Completes development and testing of second-generation sugarBEAT® wireless skin patch CCAN 11.24% – News: Enters settlement agreement for potential sale of The Clinic Network Inc. assets CTIC 10.05% – News: Enters agreement with Servier to expand license and collaboration agreement CAPR 8.89% – News: Reports positive six-month results from HOPE clinical trial NIHD 7.37% – News: Appoints new CEO CAPC 7.27% – News: Increases Q1 2017 revenue expectations BNKL 7.14%…

TuesdayApr 25, 2017 1:01 pm

NetworkNewsBreaks – Galectin Therapeutics, Inc. (NASDAQ: GALT) Receives Decision to Grant From Japanese Patent Office for GR-MD-02 Composition of Matter Patent

Galectin Therapeutics (NASDAQ: GALT) this morning said it has received a decision from the Japanese Patent Office to grant its patent application for "Composition of Novel Carbohydrate Drug for Treatment of Human Diseases." Upon issuance, the patent will expand coverage of the company's lead compound, GR-MD-02, to Japan through 2032. "The allowance of these claims in Japan further strengthens the protection of the intellectual property behind our proprietary compound, GR-MD-02. This is especially important in Japan, which was recently declared the second most attractive drug market in the world," Galectin CEO and chief medical officer Peter G. Traber, M.D. stated…

TuesdayApr 25, 2017 11:45 am

NetworkNewsBreaks – Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Leveraging Hypermatrix™ Technology to Address Key Pharmaceutical Markets

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is engaged in the research, development and commercialization of controlled-release and targeted pharmaceutical products. Leveraging its proprietary Hypermatrix™ technology, the company is focused on addressing two key niche markets, including difficult-to-produce controlled-release generic drugs (ANDA regulatory pathway) and improved current therapies through controlled-release (NDA regulatory pathway). Intellipharmaceutics' lead product is a generic of Focalin XR®, a mild central nervous system stimulant used to treat attention deficit hyperactivity disorder. This product is currently marketed in a variety of strengths by the company’s U.S. marketing partner, Par Pharmaceutical, Inc. Intellipharmaceutics’ development pipeline also includes its Rexista™ product…

MondayApr 24, 2017 2:42 pm

NetworkNewsBreaks – ORHub, Inc. (ORHB) Launches App to Streamline Efficiencies in the Operating Room

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced the anticipated second-quarter release of its new iOS and Microsoft Surface App with built-in, high-performance barcode scanning capabilities. “The ORHub iOS and Microsoft Surface App is a demonstration of how we can expand the value offered by our existing platform and empower more of the users already using ORHub to save even more time,” Wesley Mitchell, chief technology officer of ORHub, stated in the news release. “We recognize medical device sales reps as a vital customer base, and are pleased to introduce something that will help them increase efficiency and…

MondayApr 24, 2017 12:29 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 24, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: SPI 7.8% – News: Tiger Capital Fund SPC participating in Tiger Global SP agrees to purchase 80M shares of SPI for $5.76M AKER 5.56% – News: Akers Wellness™ app approved by Apple App store, available for download on iOS devices PDLI 5.20% – News: Settles patent infringement lawsuit with certain subsidiaries of Merck & Co.; will receive one-time of $19.5M payment ADHD 2.74% – News: Mails proxy materials for Extraordinary General Meeting of Shareholders…

MondayApr 24, 2017 12:29 pm

NetworkNewsBreaks – Torchlight Energy Resources, Inc. (NASDAQ: TRCH) Completes Vertical Test in Midland Basin Well

Torchlight Energy Resources (NASDAQ: TRCH) this morning said it has tested the Flying B Ranch #2 vertical well in the Lower Wolfcamp A and Upper Wolfcamp B sections, providing confirmation for the second horizontal bench in the Hazel Project. “This vertical test was a very important and successful milestone for Torchlight and its partners. This test validates our theory that commercial production of oil and gas from horizontal development in multiple stacked pay zones across different areas of our lease is achievable. As we approach the Leonard we are hopeful to prove up the potential of a third bench in…

MondayApr 24, 2017 10:43 am

NetworkNewsBreaks – RGS Energy (NASDAQ: RGSE) Rallies on Business Update, Sales Strategy

Shares of RGS Energy (NASDAQ: RGSE) are up more than 30% in morning trade after the solar company provided a business update following its presentation at the 29th Annual Roth Conference last month. RGS Energy noted its first-quarter sales increase of 194%, expected strength in the residential solar market, and how its growth strategy differs from larger peers. “I feel good about the progress we are making since we presented our strategy for top line revenue growth at the Roth conference. Our vision remains to grow top line revenue by growing the size of our sales organizations, and supporting them…

MondayApr 24, 2017 10:09 am

NetworkNewsBreaks – Aegis Capital Reiterates ‘Hold’ Rating, $2 PT on Intellipharmaceutics International, Inc. (NASDAQ: IPCI)

Aegis Capital has reiterated a ‘Hold’ rating and price target of $2 on shares of Intellipharmaceutics International (NASDAQ: IPCI). The company recently reported first quarter 2017 results with revenue of $1.2 million compared to $0.6 million in the same period of 2016. The increase in revenue is attributed to Focalin XR, per the company’s agreement with Par Pharmaceutical. The analyst expects the company to continue making progress throughout the year, with the recent launch of Par’s generic Focalin XR driving revenues. For more information, visit www.Intellipharmaceutics.com About Intellipharmaceutics Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development…

MondayApr 24, 2017 9:58 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) CEO Scheduled to Speak at the NAB Show

Internet advertising company Social Reality, Inc. (NASDAQ: SRAX) this morning announced that Christopher Miglino, its chairman and CEO, is scheduled to speak tomorrow at the NAB Show in Las Vegas. The NAB Show is the world’s largest convention encompassing the M.E.T. Effect, or the convergence of media, entertainment and technology. Miglino will be contributing to a panel titled “How Programmatic is Coming to TV” at 11:30 a.m. on April 25. The panel is part of the Fourth Annual Media Finance and Investor Program (MFIP), an official event at the NAB Show, and will be produced in partnership with Noble Capital…

MondayApr 24, 2017 9:42 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Reports 95% YOY Revenue Growth for Quarter Ended February 28, 2017

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning offered investors an update on its financial and business achievements for the fiscal third quarter ended February 28, 2017, as well as its outlook for the remainder of the current fiscal year and 2018. Among the highlights, the company reported significantly higher revenues for both the three- and nine-month periods ended February 28, 2017, as compared to the same periods of fiscal 2016, with operating revenues up 95 percent and 109 percent, respectively. Notably, CIIX has made significant progress toward expanding its presence in the rapidly-growing legal hemp industry in recent…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks